SHP2 Inhibition Displays Efficacy As a Monotherapy and in Combination with JAK2 Inhibition in Preclinical Models of Myeloproliferative Neoplasms.

Garima Pandey,Lucia Mazzacurati, Tegan M. Rowsell,Nathan P. Horvat,Narmin E. Amin,Guolin Zhang,Afua A. Akuffo,Christelle M. Colin-Leitzinger,Eric B. Haura,Andrew T. Kuykendall,Ling Zhang,Pearlie K. Epling-Burnette,Gary W. Reuther

AMERICAN JOURNAL OF HEMATOLOGY（2024）

引用 0|浏览23

暂无评分

关键词

SHP2,Ruxolitinib Therapy,JAK2 Mutation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要